AC Immune SA - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ACIU Nasdaq 2836 www.acimmune.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AC Immune SA

Leerink Says AC Immune (ACIU) Eli Lilly Tau Program Amendment Is Great News - Apr 12th, 2026 12:46 pm
ACIU Stock Rallies 16.3% in a Week: Here's What You Need to Know - Apr 9th, 2026 8:29 am
Is AC Immune (ACIU) Stock Outpacing Its Medical Peers This Year? - Apr 9th, 2026 7:40 am
April 2026's Most Promising Penny Stocks - Apr 8th, 2026 6:05 am
Why AC Immune Stock Zoomed Almost 15% Higher Today - Apr 7th, 2026 3:14 pm
Eli Lilly Extends AC Immune Tau Pact To Broaden Alzheimer’s Pipeline Potential - Apr 7th, 2026 1:10 pm
AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement with Lilly - Apr 7th, 2026 5:00 am
AC Immune Presents First In vivo Images of Brain TDP-43 Pathology from Phase 1 Trial of PET tracer ACI-19626, at AD/PDTM 2026 - Mar 19th, 2026 5:00 am
AC Immune (ACIU) Upgraded to Buy: Here's Why - Mar 18th, 2026 10:00 am
Is AC Immune (ACIU) Outperforming Other Medical Stocks This Year? - Mar 18th, 2026 7:40 am
AC Immune: Q4 Earnings Snapshot - Mar 13th, 2026 5:11 am
AC Immune Reports Full Year 2025 Financial Results and Provides a Corporate Update - Mar 13th, 2026 5:00 am
AC Immune Announces Upcoming Industry Symposium on Parkinson’s Disease and Presentation at AD/PD™ 2026 - Mar 5th, 2026 5:00 am
AC Immune Initiates Phase 1 Clinical Trial of NLRP3 Inhibitor - Feb 24th, 2026 5:00 am
Madrigal sees a stock sell-off; ex-Novartis exec heads to Daiichi - Feb 20th, 2026 3:23 am
Sector Update: Health Care Stocks Decline Late Afternoon - Feb 18th, 2026 1:46 pm
Top Penny Stocks To Watch In January 2026 - Jan 13th, 2026 11:05 am
Retail investors are AC Immune SA's (NASDAQ:ACIU) biggest owners and were rewarded after market cap rose by US$53m last week - Jan 8th, 2026 5:47 am
Discovering Opportunities: AirJoule Technologies Among 3 Promising Penny Stocks - Dec 12th, 2025 5:04 am
AC Immune posts positive data for Parkinson’s immunotherapy - Dec 11th, 2025 6:36 am